SEC 13F Intelligence

Tang Capital Management LLC / CTMX

Tang Capital Management LLC’s Cytomx Therapeutics Inc. Position

Does Tang Capital Management LLC own Cytomx Therapeutics Inc. (CTMX)? Not currently — the last reported position was 11.07M shares worth $35M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$35M
Q3 2025
Shares
11.07M
% of Portfolio
+1.36%
Quarters Held
18
position exited

Position History CTMX

Reported value by quarter
Q1 ’20: $2MQ1 ’20Q2 ’20: $2MQ3 ’20: $751,000Q4 ’21: $660,000Q4 ’21Q2 ’22: $2MQ3 ’22: $5MQ4 ’22: $6MQ4 ’22Q1 ’23: $9MQ2 ’23: $11MQ3 ’23: $8MQ3 ’23Q4 ’23: $10MQ1 ’24: $14MQ2 ’24: $10MQ2 ’24Q3 ’24: $9MQ4 ’24: $8MQ1 ’25: $4MQ1 ’25Q2 ’25: $25MQ3 ’25: $35Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 202511.07M$35M+1.36%
Q2 202511.07M$25M+1.27%
Q1 20256.72M$4M+0.24%
Q4 20247.31M$8M+0.50%
Q3 20247.81M$9M+0.66%
Q2 20247.79M$10M+0.97%
Q1 20246.45M$14M+1.46%
Q4 20236.55M$10M+0.94%
Q3 20236.45M$8M+1.17%
Q2 20236.60M$11M+1.67%
Q1 20236.09M$9M+1.37%
Q4 20223.51M$6M+0.82%
Q3 20223.50M$5M+0.62%
Q2 20221.05M$2M+0.29%
Q4 2021152.3K$660,000+0.13%
Q3 2020112.9K$751,000+0.14%
Q2 2020300.0K$2M+0.24%
Q1 2020300.0K$2M+0.32%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tang Capital Management LLC’s full portfolio or all institutional holders of CTMX.